drugset / Trial / NCT00044265

Treatment of Pediatric Hypertension With Altace Trial

NCT00044265

RandomizedCrossoverDouble-blindTreatment

Summary

Ramipril is an ACE inhibitor that has been marketed in the US for the treatment of hypertension since 1991. It has been shown to be effective in reducing both systolic and diastolic blood pressure in adults when used once daily. ACE inhibitors are frequently used to treat hypertension in children, however ramipril has not been extensively tested in children, and information regarding the efficacy and safety would therefore be of benefit to children. This study is designed to demonstrate the efficacy and safety of ramipril in the treatment of hypertension in children ages 6 through 16 years.

Timeline

Start
2002-07
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule

Indications